Skip to content
2000
Volume 6, Issue 4
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Gross total resection, though proven to be effective, is often hindered by the notoriously challenging differentiation between malignant glioma and the surrounding edematous brain when using standard white light microscopy. Intraoperative imaging or neuronavigation by preoperative datasets deliver inconsistent results as they often fail to demonstrate tumor or resection borders reliably. With the introduction of the 5-aminolevulinic acid (5-ALA, Gliolan®) fluorescence microscopy, neurosurgeons command a highly specific biological tumor marker for malignant glioma resection, to help distinguish the vital tumor tissue from normal brain and improve the extent of tumor removal.

Loading

Article metrics loading...

/content/journals/cmir/10.2174/157340510793205503
2010-11-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/cmir/10.2174/157340510793205503
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test